ZEVRA THERAPEUTICS, INC. (ZVRA)
Pharmaceutical Preparations · Healthcare · $748M
Intrinsic Value (Consensus)
$16.34
Current Price
$12.65
Margin of Safety
+29.2%
29.2% Below Intrinsic Value
Value: $16
Price: $13
Valuation Model Estimates
Current Price: $12.65
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$8.91
Earnings Power Value
$13.11
Relative Value (P/E)
$27.00
Dividend Discount Model
Not applicable
—
Consensus Value
$16.34
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
60
Profitability
25/25
Strength
12/25
Valuation
19/25
Growth
4/25
Financial Health Signals
Negative free cash flow — company is burning cash
Strong profitability — ROE of 54% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $1.35
- EPS (Forward)
- $1.42
- Book Value
- $2.62
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 53.8%
- Debt/Equity
- 40%
- Revenue Growth
- N/A
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance